Read the latest HealthWatch newsletter: Issue 113, Summer 2020
Latest news: The vast AgeX breast screening trial ended, ever so quietly. What did it cost and who approved the spend?
PharmaTimes head-to-head debate beteween author, doctor and journalist Ben Goldacre and the Association of the British Pharmaceutical Industry's chief executive, Stephen Whitehead
Read the article here.
Are you for science and integrity in healthcare?
Already a member?
Tweets by @HealthWatchUK